Your Proposed Taper is Too Rapid and Risks Significant Withdrawal Symptoms
Your proposed 3-week mirtazapine taper (30→15→7.5 mg over 3 weeks) is too aggressive and should be extended to at least 10-14 days per dose reduction, with the option to go much slower if you've been on it long-term. The concurrent initiation of doxepin 10 mg at bedtime is reasonable for managing insomnia during the transition.
Why Your Taper Needs to Be Slower
Guideline-Based Tapering Recommendations
The FDA label for mirtazapine explicitly states to "reduce dose gradually when discontinuing" 1. More specifically, antidepressant discontinuation guidelines recommend tapering over 10-14 days minimum to limit withdrawal symptoms 2. For patients on antidepressants long-term (≥1 year), tapers of 10% per month or slower are better tolerated than rapid tapers 3.
Your 1-week intervals at each dose are problematic because:
- Mirtazapine has a 20-hour half-life 4, meaning steady-state takes 4-6 days to achieve after each dose change
- Abrupt or rapid discontinuation causes withdrawal symptoms including panic attacks, anxiety, insomnia, dizziness, and nausea 5—one case report documented severe, recurrent panic attacks lasting 5 days after abrupt mirtazapine cessation after only 10 weeks of treatment
- Recent research shows that alternate-day dosing or rapid tapers increase receptor occupancy variation, triggering withdrawal symptoms 6
Modified Taper Schedule
Recommended approach:
- Week 1-2: Mirtazapine 30 mg daily
- Week 3-4: Mirtazapine 15 mg daily
- Week 5-6: Mirtazapine 7.5 mg daily
- Week 7+: Discontinue
If you experience withdrawal symptoms (anxiety, insomnia worsening, dizziness, nausea, agitation), slow the taper further—some patients require several months 7, 8.
Starting Doxepin Concurrently
Initiating doxepin 10 mg at bedtime while tapering mirtazapine is appropriate and supported by guidelines 7, 9.
Key Points About Doxepin:
- Low-dose doxepin (3-10 mg) is specifically recommended for sleep maintenance insomnia 9—the American Academy of Sleep Medicine suggests using it as treatment versus no treatment
- Doxepin at low doses improves sleep without significant anticholinergic effects seen at antidepressant doses 10
- Start doxepin when you begin the mirtazapine taper (not after discontinuation) to provide continuous sleep support and minimize insomnia rebound
- Both medications are sedating antidepressants used off-label for insomnia 7, so the transition makes pharmacological sense
Important Caveats:
- Monitor for excessive sedation when combining these medications initially, as both have CNS depressant effects 11
- Avoid alcohol and benzodiazepines during this transition 1
- Doxepin 10 mg is higher than the FDA-studied doses (3-6 mg) for insomnia 9, but is commonly used in clinical practice 12
- Watch for anticholinergic effects (dry mouth, constipation, urinary retention) though these are less common at 10 mg
Critical Monitoring During Taper
Watch for these withdrawal symptoms that signal you need to slow down:
- Anxiety, agitation, or panic attacks
- Worsening insomnia beyond baseline
- Dizziness, "brain zaps," or sensory disturbances
- Nausea, diarrhea, flu-like symptoms
- Mood instability or irritability
If withdrawal symptoms emerge: Hold at current dose for 1-2 weeks until symptoms resolve, then resume tapering at a slower rate (e.g., 25% dose reduction every 2-4 weeks) 13, 11.
Why This Matters for Your Outcomes
Rapid antidepressant discontinuation increases risk of:
- Relapse of underlying depression/anxiety (HR 2.97 for tapers <4 weeks) 8
- Rebound insomnia that may be worse than baseline 7
- Withdrawal syndrome that can be confused with relapse, leading to unnecessary medication reinitiation 8
The goal is successful discontinuation without destabilizing your sleep or mood—this requires patience with the taper timeline.